Cargando…
Antihepatitis C virus therapy in liver transplanted patients
Hepatitis C virus (HCV) management in the transplant setting is still an open issue. The therapeutic strategies being addressed include: (a) pre-transplant prophylaxis (to prevent the infection of the transplanted organ); (b) post-transplant prophylaxis (to reduce the possibility of developing acute...
Autor principal: | Picciotto, Antonino |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661645/ https://www.ncbi.nlm.nih.gov/pubmed/18360580 |
Ejemplares similares
-
Antihepatic Fibrosis Drugs in Clinical Trials
por: Guo, Yue-Cheng, et al.
Publicado: (2020) -
Seroconversión de la vacuna recombinante antihepatitis B. /
por: Cetina Ruz, Mirna Patricia
Publicado: (1996) -
High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use
por: Tamori, Akihiro, et al.
Publicado: (2020) -
A QSAR study on some series of antihepatitis B virus (HBV) agents
por: Arora, Preet K, et al.
Publicado: (2010) -
Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy
por: Urraro, Teresa, et al.
Publicado: (2015)